Should you invest in Aleafia Health Stock? Recommendation: Keep Reading
Aleafia Health, Inc. ALEF (TSE) & ALEAF (OTC) specializes in cannabis healthcare solutions. They operate medical cannabis clinics, processing and distribution facilities, and research and development centers. Aleafia Health was listed in the 50 top-performing companies for 2019 amongst all 2,000 TSX Venture Exchange listed companies.
Aleafia Health: Company Profile
HQ: Ontario, Canada
Facilities: Niagara, Port Perry, Paris
Symbol: ALEF (TSE) & ALEAF (OTC)
Aleafia Health: Strong Focus
Aleafia Health is a vertically-integrated cannabis company focused on offering cannabis-related health and wellness products. Aleafia Health produces cannabis capsules, oil, and sprays from their three licensed cannabis production facilities in Canada. Aleafia Health is focused on expanding its network of medical cannabis education centers and clinics across Northern America and Europe.
Aleafia Health: Neutral Size
Market Cap: US $70.8 mil
Enterprise Value: US $77.6 mil
Number of employees: 173
Aleafia Health: Strong Markets
Aleafia Health: Strong Operations
Cultivation: 13,000 kg per year. Ramping up to 115,000 kg per year after new license approvals.
Direct sales: N/A
Store networks: Joint venture with Flying High brands to distribute their products
Supply agreements: In October 2019, Aleafia Health made an announcement regarding the termination of a supply agreement with Aphria. Aphria failed to meet its supply obligations and the issue is referred to as confidential arbitration.
Registered patients: 70,000.
Aleafia Health: Neutral Financials
- Revenue last quarter was $6.0 million.
- Margins: 75%
- Shares Outstanding (diluted): 277.9 mil
- EPS (diluted): (0.03)
Aleafia Health: Neutral Management
CEO: Geoffrey Benic
CFO: Benjamin Ferdinand
Geoffrey Benic, CEO of Aleafia Health, has more than 15 years of experience in the logistics and supply chain industry implementing a vertical integration growth strategy. Benjamin Ferdinand, CFO of Aleafia Health, brings vast experience of fundraising having a background in the investment banking industry.
Aleafia Health: Strong Branding
Aleafia Health: Neutral Valuation
- Current share price: US $0.307
- Price to Sales: 4.81 (Biopharma industry average = 7.5)
- EV / Revenue: 4.74
- 52 week low/high: US $0.20-$1.38
- Price/Book: 0.26
Aleafia Health: Strong Financings
Aleafia Health: High Risks
Aleafia Health: Strong Recommendation
Aleafia Health is a vertically integrated company focused on offering cannabis-related health and wellness products. Aleafia Health produces cannabis capsules, oil, and sprays from their three licensed cannabis production facilities in Canada.
Aleafia Health was listed in the 50 top-performing companies for 2019 amongst all 2,000 TSX Venture Exchange listed companies.
Aleafia Health is focused on expanding its network of medical cannabis education centers and clinics across Northern America and Europe.
Geoffrey Benic, CEO of Aleafia Health, has more than 15 years of experience in the logistics and supply chain industry implementing a vertical integration growth strategy. Benjamin Ferdinand, CFO of Aleafia Health, brings vast experience of fundraising with a background in the investment banking industry.
Aleafia is in the process of increasing its extraction capacity from 13,000 kg to 115,000 kg after their pending license is approved. Aleafia Health is supporting its patient acquisition and data gathering initiatives through its portfolio of cannabis medical clinics under an integrated model. Aleafia Health has built a portfolio of formulations and brands for recreational and medical cannabis markets.
Will Aleafia’s stock price improve in the long term? Very Likely.
By December 31, 2019, Aleafia Health had cash equivalents and short-term investments were $41.2 million, which is sufficient to cover the cost of operations in 2020.
Aleafia Health is very responsive to market conditions as they recently started the “last-mile home” delivery service of medical cannabis during the COVID-19 pandemic in the spring of 2020.
Aleafia Health revenues grew 27% in the fourth quarter as to $6 million as compared to last quarter however they faced a net loss of $9.8 million as compared to a net loss of $1.9 million in the third quarter. The rise in net loss was due to gain non-cash expenses related to the fair value of biological assets and deferred income tax expense.
For these reasons, we suggest Aleafia Health, at or near its current price of $0.30 a share, can be a good investment opportunity.
Aleafia Health: Featured Cannabis Stock
About Cannin: Your Marijuana Investment Experts
Cannin is your trusted resource for information about marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. We provide the latest marijuana investment and hemp investment news and analysis.
Use Cannin as your resource for breaking cannabis and hemp investing news, featured cannabis and hemp company analysis, comprehensive cannabis and hemp stock reports, or get your free trial now and use our Smart Stock Algorithm to take the guesswork out of profiting from the cannabis industry. Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest. Aleafia Health: Featured Cannabis Stock is blazing a strong path forward in the cannabis industry.
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
Profit from the best marijuana stocks – we’ll show you how at cannin.com